Opioids switching with transdermal systems in chronic cancer pain.
about
Oxymorphone Extended-Release Tablets (Opana ER) For the Management of Chronic Pain: A Practical Review for PharmacistsTransdermal buprenorphine - a critical appraisal of its role in pain management.European Palliative Care Research Collaborative pain guidelines: opioid switching to improve analgesia or reduce side effects. A systematic review.Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review.Safety and efficacy of transdermal buprenorphine for the relief of cancer pain.End-of-dose pain in chronic pain: does it vary with the use of different long-acting opioids?A meta-analysis of efficacy and tolerability of buprenorphine for the relief of cancer pain.Systematic review of adverse events of buprenorphine patch versus fentanyl patch in patients with chronic moderate-to-severe pain.The clinical analgesic efficacy of buprenorphine.Buprenorphine for cancer pain: is it ready for prime time?Dosing considerations with transdermal formulations of fentanyl and buprenorphine for the treatment of cancer pain.Transdermal buprenorphine and fentanyl patches in cancer pain: a network systematic review.Effect of transdermal opioids in experimentally induced superficial, deep and hyperalgesic pain.A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain.Substance P and beta-endorphin mediate electro-acupuncture induced analgesia in mouse cancer pain model.Use of immediate-release opioids as supplemental analgesia during management of moderate-to-severe chronic pain with buprenorphine transdermal system.
P2860
Q33924852-93DC11D7-88BE-43E2-B2DC-A845F13C231BQ34418193-7D8C09E2-C01A-4E72-8033-0777D1CCA189Q37894996-6B4C6AF2-19E5-4F51-AB6C-A95DE5839E59Q37894998-43EA8679-552A-451E-9433-D765320BCB47Q38127157-A1C5AA20-56BB-452F-8C40-1D77A8BAC652Q38174282-6A8644A5-5118-4EB1-B148-D9764DA6878DQ38193819-D66C132F-1D1E-4767-98FD-9DBBB87FB38BQ38198100-09D77915-C162-4B53-A8E4-C734C024584DQ38234808-0D1AAE9D-4ABA-4BC5-8E30-F3CCC6035B91Q38243938-71610E79-2FF5-443B-8BC6-156915CC6508Q38244523-E18A77BF-4829-408C-BD7D-E99EFA39F03AQ38399076-67568C10-F0DE-4D04-9ADD-355CB324E96AQ38739959-E01BE6F3-27C1-41D2-8313-6E3B8124D1FCQ39234435-1D765795-4D29-4D97-BE83-2DF7AA217EF6Q39824737-B1209DEB-DECE-4410-A525-6582FC82CE10Q42237962-518BD275-B525-4A52-BCCA-A0BA816FDDED
P2860
Opioids switching with transdermal systems in chronic cancer pain.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Opioids switching with transdermal systems in chronic cancer pain.
@en
Opioids switching with transdermal systems in chronic cancer pain.
@nl
type
label
Opioids switching with transdermal systems in chronic cancer pain.
@en
Opioids switching with transdermal systems in chronic cancer pain.
@nl
prefLabel
Opioids switching with transdermal systems in chronic cancer pain.
@en
Opioids switching with transdermal systems in chronic cancer pain.
@nl
P2093
P2860
P50
P356
P1476
Opioids switching with transdermal systems in chronic cancer pain
@en
P2093
M B Passavanti
M Barbarisi
P2860
P2888
P356
10.1186/1756-9966-28-61
P577
2009-05-07T00:00:00Z
P5875
P6179
1021888183